Please note that the content of this book primarily consists of
articles available from Wikipedia or other free sources online. The
Cabilly patents are two US patents issued to Genentech which relate
to the "fundamental technology required for the artificial
synthesis of antibody molecules." The name refers to the lead
inventor Shmuel Cabilly. There has been ongoing legal controversy
surrounding these patents since the original filing in 1983. An
interference between U.S. Patent 4,816,567 (the original "Cabilly
patent") issued to Genentech and U.S. Patent 4,816,397 (the "Boss"
patent) issued to Celltech resulted in the issuance of a second
"Cabilly patent" to Genentech in 2001. This new patent would
therefore extend into 2018, an effective term of 29 years.
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!